AQUAVAC® ERM

Species

Diseases Treated

Country

Environment

Our Solutions (for vets)

AQUAVAC® ERM



Inactivated, immersion vaccine against Enteric Redmouth Disease caused by Yersinia ruckeri (Hagerman strain) in rainbow trout (Oncorhynchus mykiss).

Key Features 

  • Protection for small fry: AquaVac ERM can be administered by immersion to trout fry from 2g. Optimum protection is achieved at 4-5g.
  • Cross-protection against a range of clinically significant Yersinia ruckeri isolates from Europe, Norway and Chile.
  • Immersion vaccine with more than 1 billion doses used in European trout farming.
  • Part of disease control program for the most common disease in farmed trout. 
  • Excellent safety profile. 
  • Primary vaccine for farms only at risk from Biotype 1 strains of Yersinia ruckeri - for more information on Biotype 2 and associated etiology please go to AquaVac RELERA  

 

Key Benefits

  • Increase survival in fry and juvenile rainbow trout.
  • Safe and easy to use in fry as small as 2 g.
  • Efficacy demonstrated in Europe, North America and Latin America.

  • Forms part of a Total Protection Strategy against Enteric Redmouth Disease caused by biotype 1 strains of Yersinia ruckeri. For use as the priming dose for AquaVac ERM Oral.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AQUAVAC® is the property of Intervet International B.V. or affiliated companies or licensors and is protected by copyrights, trademark and other intellectual property laws.

NOTE: Specific product details of indications, registration license status, and trademarks, etc. may vary from country to country. Users should check the license status, local label and/or data sheet for exact specifications of usage or contact the local Intervet/Schering-Plough Animal Health representative.